ArticleFrontiers in endocrinology2026
Age-stratified hormonal profiles in adolescent and young adult PCOS/PMOS: higher mid-adolescent AMH largely unexplained by BMI.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovary syndrome (PCOS) - for which a global multistakeholder consensus has recently proposed the name polyendocrine metabolic ovarian syndrome (PMOS) - shows phenotypic variation across adolescence that is poorly characterised in Turkish populations, and because puberty raises both body mass index (BMI) and reproductive hormones in parallel, age and BMI effects are potentially confounded. Within a single-centre retrospective cohort of clinician-assigned PCOS/PMOS (January 2024-February 2026), we described how hormonal, anthropometric and clinical profiles differ across age and whether these differences are explained by the parallel BMI gradient; because the cohort has no healthy controls, all analyses describe intra-PCOS variation and cannot establish PCOS-specificity. Of 1,228 patients with a clinician-assigned PCOS diagnosis among 11,324 adolescent visits, 878 met inclusion criteria (94.5% fulfilled ≥2 Rotterdam criteria
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.